Individual Hymenoptera Venom Compounds Induce Upregulation of the Basophil Activation Marker Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 (CD203c) in Sensitized PatientsBinder M.a · Fierlbeck G.b · King T.P.c · Valent P.d · Bühring H.-J.a
aDepartment of Internal Medicine II, Division of Hematology and Immunology and bDepartment of Dermatology, Division of Allergology, University of Tübingen, Germany; cRockefeller University, New York, N.Y., USA; dDepartment of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Austria
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Bee and wasp venom extracts contain potent allergens capable of inducing severe clinical reactions. To analyze immediate-type hypersensitivity to defined hymenoptera venom components, a recently developed in vitro test was applied that is based on the upregulation of CD203c expression on basophils. Methods: CD203c expression on blood basophils of 9 healthy donors and 39 patients allergic to bee and/or wasp venom was analyzed by flow cytometry before and after activation with the purified bee venom allergens phospholipase A2 (Api m 1), hyaluronidase (Api m 2) and melittin (Api m 4), or the purified wasp venom allergens phospholipase A1 (Ves v 1), hyaluronidase (Ves v 2) and the recombinant antigen 5 (Ves v 5). Venom-induced CD203c upregulation on basophils was compared with skin tests and assessment of specific IgE. Basophils of nonresponders were preincubated with 10 ng/ml interleukin-3 (IL-3) prior to allergen stimulation. Results: CD203c upregulation on basophils was induced by defined hymenoptera venom components in 35/39 patients with a diagnosed allergy to wasp and/or bee venom. Twenty-seven of the 34 tested patients with wasp allergy showed CD203c upregulation in response to Ves v 5, 26 of these patients also reacted with Ves v 2 and 17 with Ves v 1. Nine of 13 patients with bee allergy reacted with Api m 1, 13 individuals with Api m 2 and none of these patients with the minor allergen Api m 4. A diagnosed wasp allergy could also be confirmed in the prestimulated basophils (IL-3) of 2 nonresponder individuals who failed to upregulate CD203c in response to IgE receptor cross-linking prior to culture with IL-3. Conclusions: Flow-cytometric determination of CD203c upregulation on basophils activated by molecularly defined allergens is a powerful method to identify the precise allergen reactivity in sensitized individuals.
© 2002 S. Karger AG, Basel
Kay AB: Allergy and Allergic Diseases. Oxford, Blackwell Science, 1997.
Minkhar M, Giffard G, Lauret MG, Hassoun S, Drouet M, Sainte-Laudy J, Sabbah A: Histamino-libération (ou histamine release HR): Etude du seuil de positivité dans l`allergie aux venins d`hyménoptères. Allergie Immunol 1996;9:313–316.
- Chapman D, Vervloet D, Haddi E: Prevalence of allergy to hymenoptera stings. Allergy Proc 1990;11:29–32.
- Mosbech H: Death caused by wasp and bee stings. Allergy 1983;38:195–200.
- Platz IJ, Binder M, Marxer A, Lischka G, Valent P, Bühring HJ: Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals. Int Arch Allergy Immunol 2001;126:335–342.
- Pâris-Köhler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B: In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000;105:339–345.
- Gane P, Pecquet C, Lambin P, Abuaf N, Leynadier F, Rouger P: Flow cytometric evaluation of human basophils. Cytometry 1993;14:344–348.
- Gane P, Pequet C, Crespeau H, Lambin P, Leynadier F, Rouger P: Flow cytometric monitoring of allergen induced basophil activation. Cytometry 1995;19:361–365.
- Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D: Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88:328–338.
- Siegmund R, Vogelsang H, Machnik A, Herrmann D: Surface membrane antigen alteration on blood basophils in patients with hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol 2000;106:1190–1195.
- Hauswirth AW, Natter S, Ghannadan M, Majlesi Y, Schernthaner GH, Sperr WR, Bühring HJ, Valenta R, Valent P: Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol 2002;110:102–109.
- Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM: Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999;104:279–284.
Valent P, Bettelheim P: The human basophil. Crit Rev Hematol Oncol 1990;10:327–352.
- Bühring HJ, Simmons PJ, Pudney M, Müller M, Jarrossay D, van Agthoven A, Willheim M, Brugger W, Valent P, Kanz L: The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multi- potent and unipotent progenitors. Blood 1999;94:2343–2356.
- Bühring HJ, Seiffert M, Giesert C, Marxer A, Kanz L, Valent P, Sano K: The basophil activation marker defined by antibody 97A6 is identical with the ectonucleotide pyrophosphatase/phosphodiesterase 3. Blood 2001;97:3303–3305.
- King TP, Spangford MD: Structure and biology of stinging insect venom allergens. Int Arch Allergy Immunol 2000;123:99–106.
- King TP, Jim SY, Monsalve RI, Kagey-Sobotka A, Lichtenstein LM, Spangfort MD: Recombinant allergens with reduced allergenicity but retaining immunogenicity of the natural allergens: Hybrids of yellow jacket and paper wasp venom allergen antigen 5s. J Immunol 2001;166:6057–6065.
- King TP, Lu G, Gonzalez M, Qian N, Soldatova L: Yellow jacket venom allergens, hyaluronidase and phospholipase: Sequence similarity and antigenic cross-reactivity with their hornet and wasp homologs and possible implications for clinical allergy. J Allergy Clin Immunol 1996;98:588–600.
Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H, Scheiner O, Breitenbach M: The gene coding for the major birch pollen allergen Betv1 is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935–1938.
- Susani M, Jertschin P, Dolecek C, Sperr WR, Valent P, Ebner C, Kraft D, Valenta R, Scheiner O: High level expression of birch pollen profilin (Bet v 2) in Escherichia coli: Purification and characterization of the recombinant allergen. Biochem Biophys Res Commun 1995;215:250–263.
- Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D: Recombinant allergens. Allergy 1998;53:552–561.
- Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C, Kraft D, Valenta R: Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5). J Allergy Clin Immunol 1996;97:781–787.
- Dudler T, Chen WQ, Wang S, Schneider T, Annand RR, Dempcy RO, Crameri R, Gmachl M, Suter M, Gelb MH: High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochim Biophys Acta 1992;1165:201–210.
- Scott DL, Otwinowski Z, Gelb MH, Sigler PB: Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science 1990;250:1563–1566.
- Mueller HL: Diagnosis and treatment of insect sensitivity. J Asthma Res 1966;3:331–336.
- King TP, Sobotka AK, Kochoumian L, Lichtenstein LM: Allergens of honey bee venom. Arch Biochem Biophys 1976;172:661–671.
- King TP, Alagon AC, Kuan J, Sobotka AK, Lichtenstein LM: Immunochemical studies of yellowjacket venom proteins. Mol Immunol 1983;20:297–308.
- Monsalve RI, Lu G, King TP: Expressions of recombinant venom allergen, antigen 5 of yellowjacket (Vespula vulgaris) and paper wasp (Polistes annularis), in bacteria or yeast. Protein Expr Purif 1999;16:410–416.
- Yamaguchi M, Hirai K, Otha K, Suzuki K, Kitani S, Takaishi T, Ito K, Ra C, Morita Y: Nonreleasing basophils convert into releasing basophils by culturing with IL-3. J Allergy Clin Immunol 1996;97:1279–1287.
- Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, Barletta B, Becker WM, Blaser K, Breiteneder H, Chapman M, Crameri R, Duchene M, Ferreira F, Fiebig H, Hoffmann-Sommergruber K, King TP, Kleber-Janke T, Kurup VP, Lehrer SB, Lidholm J, Muller U, Pini C, Reese G, Scheiner O, Scheynius A, Shen HD, Spitzauer S, Suck R, Swoboda I, Thomas W, Tinghino R, Van Hage-Hamsten M, Virtanen T, Kraft D, Muller MW, Valenta R: Microarrayed allergen molecules: Diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414–416.
- Sobotka AK, Malveaux FJ, Marone G, Thomas LL, Lichtenstein LM: IgE-mediated basophil phenomena: Quantitation, control, inflammatory interactions. Immunol Rev 1978;41:171–185.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.